CEMI
Income statement / Annual
Last year (2022), Chembio Diagnostics, Inc.'s total revenue was $48.34 M,
an increase of 30.91% from the previous year.
In 2022, Chembio Diagnostics, Inc.'s net income was -$23.29 M.
See Chembio Diagnostics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$48.34 M
|
$36.93 M
|
$30.45 M
|
$34.46 M
|
$33.41 M
|
$24.02 M
|
$17.87 M
|
$24.26 M
|
$27.65 M
|
$29.55 M
|
| Cost of Revenue |
$38.58 M |
$34.50 M |
$23.87 M |
$22.39 M |
$21.43 M |
$12.92 M |
$9.42 M |
$13.77 M |
$16.83 M |
$17.25 M |
| Gross Profit |
$9.76 M |
$2.43 M |
$6.58 M |
$12.07 M |
$11.98 M |
$11.09 M |
$8.45 M |
$10.49 M |
$10.81 M |
$12.30 M |
| Gross Profit Ratio |
0.2 |
0.07 |
0.22 |
0.35 |
0.36 |
0.46 |
0.47 |
0.43 |
0.39 |
0.42 |
| Research and Development
Expenses |
$7.07 M
|
$12.49 M
|
$9.51 M
|
$8.54 M
|
$8.53 M
|
$8.56 M
|
$8.43 M
|
$6.38 M
|
$4.83 M
|
$5.83 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$6.15 M
|
$5.73 M
|
$4.48 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.51 M
|
$1.78 M
|
$1.01 M
|
| Selling, General &
Administrative Expenses |
$24.28 M
|
$24.84 M
|
$21.04 M
|
$16.14 M
|
$11.10 M
|
$9.02 M
|
$7.60 M
|
$7.66 M
|
$7.50 M
|
$5.49 M
|
| Other Expenses |
-$1.18 M |
-$10.89 M |
-$2.02 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
-$4,814.00 |
-$5,707.00 |
$7,500.00 |
| Operating Expenses |
$30.16 M |
$26.44 M |
$28.53 M |
$24.68 M |
$19.63 M |
$17.58 M |
$16.02 M |
$14.04 M |
$12.36 M |
$11.30 M |
| Cost And Expenses |
$68.74 M |
$60.93 M |
$52.40 M |
$47.07 M |
$41.05 M |
$30.50 M |
$25.44 M |
$27.81 M |
$29.20 M |
$28.54 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
-$846,831.00 |
$49,498.00 |
$25,430.00 |
$25,548.00 |
$2,412.00 |
$5,839.00 |
$5,778.00 |
| Interest Expense |
$382,000.00 |
$2.91 M |
$2.84 M |
-$846.83 M |
$0.00 |
$2,945.00 |
$0.00 |
$836.00 |
$0.00 |
$335.00 |
| Depreciation &
Amortization |
$5.79 M
|
$2.93 M
|
$2.70 M
|
$721,465.00
|
$337,645.00
|
$1.28 M
|
$1.14 M
|
$1.37 M
|
$739,297.00
|
$607,822.00
|
| EBITDA |
-$14.61 M
|
-$21.07 M
|
-$19.25 M
|
-$11.89 M
|
-$7.31 M
|
-$5.18 M
|
-$6.41 M
|
-$2.18 M
|
-$810,824.00
|
$1.63 M
|
| EBITDA Ratio |
-0.3 |
-0.57 |
-0.63 |
-0.34 |
-0.22 |
-0.22 |
-0.36 |
-0.09 |
-0.03 |
0.06 |
| Operating Income Ratio
|
-0.42
|
-0.65
|
-0.72
|
-0.37
|
-0.23
|
-0.27
|
-0.42
|
-0.15
|
-0.06
|
0.03
|
| Total Other
Income/Expenses Net |
$381,795.00
|
-$9.96 M
|
-$2.84 M
|
-$846,831.00
|
$49,498.00
|
$22,485.00
|
$25,548.00
|
-$3,238.00
|
$132.00
|
$12,943.00
|
| Income Before Tax |
-$23.26 M |
-$33.97 M |
-$25.98 M |
-$14.18 M |
-$7.93 M |
-$6.46 M |
-$7.55 M |
-$3.56 M |
-$1.55 M |
$1.02 M |
| Income Before Tax Ratio
|
-0.48
|
-0.92
|
-0.85
|
-0.41
|
-0.24
|
-0.27
|
-0.42
|
-0.15
|
-0.06
|
0.03
|
| Income Tax Expense |
$34,405.00 |
-$62,050.00 |
-$456,794.00 |
-$500,292.00 |
-$67,521.00 |
-$88,305.00 |
$5.80 M |
-$1.16 M |
-$412,918.00 |
$486,952.00 |
| Net Income |
-$23.29 M |
-$33.90 M |
-$25.52 M |
-$13.68 M |
-$7.87 M |
-$6.37 M |
-$13.35 M |
-$2.40 M |
-$1.14 M |
$530,818.00 |
| Net Income Ratio |
-0.48 |
-0.92 |
-0.84 |
-0.4 |
-0.24 |
-0.27 |
-0.75 |
-0.1 |
-0.04 |
0.02 |
| EPS |
-0.96 |
-1.4 |
-1.34 |
-0.81 |
-0.54 |
-0.52 |
-1.26 |
-0.25 |
-0.12 |
0.06 |
| EPS Diluted |
-0.96 |
-1.4 |
-1.34 |
-0.81 |
-0.54 |
-0.52 |
-1.26 |
-0.25 |
-0.12 |
0.06 |
| Weighted Average Shares
Out |
$24.30 M
|
$24.30 M
|
$19.09 M
|
$16.95 M
|
$14.43 M
|
$12.30 M
|
$10.62 M
|
$9.63 M
|
$9.53 M
|
$8.99 M
|
| Weighted Average Shares
Out Diluted |
$24.30 M
|
$24.30 M
|
$19.09 M
|
$16.95 M
|
$14.43 M
|
$12.30 M
|
$10.62 M
|
$9.63 M
|
$9.53 M
|
$9.52 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
